Bringing a Cancer Doctor ’s Perspective to FDA’s Response to the COVID-19 Pandemic

During the unprecedented COVID-19 pandemic, the FDA recognizes that there has been public interest around expediting the development and availability of a number of potential treatment options.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news